Israeli focused-ultrasound developer InSightec has received regulatory approval from the Australian and Taiwanese governments for the commercial distribution of its ExAblate 2000 MR-guided focused ultrasound (MRgFUS) system.
The incisionless surgery system is used for the treatment of uterine fibroids, according to the Haifa-based vendor.
By AuntMinnie.com staff writers
June 21, 2006
Copyright © 2006 AuntMinnie.com